Stock repurchasing
This article was originally published in The Gray Sheet
Executive Summary
Hologic and Cohesion Technologies are among the latest to initiate stock repurchase programs in the wake of volatility in the broader market. Bone densitometry firm Hologic and surgical sealant developer Cohesion both plan to repurchase up to 1 mil. shares. Other firms announcing stock repurchase programs include Biosite Diagnostics (1 mil. shares); Chronimed (1 mil. shares); Respironics (1 mil. shares); Perclose (500,000 shares); Ventana Medical Systems (750,000 shares); and Bionx Implants (unspecified). Safeskin's 2 mil. share repurchase program is 75% complete